Over the past 10 years we have come to appreciate the dynamic state of genomes , including both DNA modi - fications and RNA quantitative and qualitative changes , which have been characterized in species ranging from simple model organisms to humans . This advance has occurred through the use of various genomic meas - urements , including comprehensive transcriptomics studies 1 . We now have a new appreciation for the com - plexity of the transcriptome , encompassing a multitude of previously unknown coding and non - coding RNA species , particularly small RNAs ( sRNAs ) , including microRNAs , promoter - associated RNAs and newly dis - covered antisense 3 ′ termini - associated RNA , to name a few 2 , 3 . Initial transcriptomics studies largely relied on hybridization - based microarray technologies and offered a limited ability to fully catalogue and quantify the diverse RNA molecules that are expressed from genomes over wide ranges of levels . The introduction of high - throughput next - generation DNA sequencing ( NGS ) technologies 4 revolutionized transcriptomics by allow - ing RNA analysis through cDNA sequencing at massive scale ( RNA - seq ) . This development eliminated several challenges posed by microarray technologies , including the limited dynamic range of detection 5 . NGS platforms used for RNA - seq are commercially available from four companies — Illumina , Roche 454 , Helicos BioSciences and Life Technologies — and new technologies are in development by others 4 . Given the importance of sequencing capabilities , such as throughput , read length , error rate and ability to perform paired reads , for RNA - seq as well as genomic studies , NGS companies are constantly improving their platforms to provide the best sequencing performance at the lowest cost 4 . New methodologies for RNA - seq studies have been providing a progressively fuller knowledge of both the quantitative and qualitative aspects of transcript biology in both prokaryotes 6 and eukaryotes 5 . Here we discuss these advances , which have included the development of approaches to allow a more comprehensive understand - ing of transcription initiation sites , the cataloguing of sense and antisense transcripts , improved detection of alternative splicing events and the detection of gene fusion transcripts , which has become increasingly important in cancer research — all at a data scale that was unimagined just several years ago . Recently devel - oped approaches also allow the selection of specific RNA molecules before RNA - seq , allowing transcriptom - ics studies with more focused aims . In this Review , we provide an overview of these methods , touching only briefly on the types of biological insight that they allow , and focusing on the technologies themselves . We pro - vide a comparison of the different approaches that are available for each application and discuss the current limitations and the potential for future improvements . We conclude by discussing two new developments in RNA - seq technologies : direct RNA sequencing ( DRS ) 7 and methods for the reliable profiling of minute RNA quantities , which is important for translational research and clinical applications of RNA - seq . Mapping transcription start sites The mapping of transcription start sites ( TSSs ) at nucleotide resolution is necessary to fully define RNA Helicos BioSciences Corporation , One Kendall Square , Cambridge , Massachusetts 02139 , USA . e - mails : fozsolak @ helicosbio . com ; pmilos @ helicosbio . com doi : 10 . 1038 / nrg2934 Published online 30 December 2010 Next generation DNA sequencing ( Often abbreviated to NGS . ) Non - Sanger - based high - throughput DNA sequencing technologies . Compared to Sanger sequencing , NGS platforms sequence as many as billions of DNA strands in parallel , yielding substantially more throughput and minimizing the need for the fragment - cloning methods that are often used in Sanger sequencing of genomes . RNA sequencing : advances , challenges and opportunities Fatih Ozsolak and Patrice M . Milos Abstract | In the few years since its initial application , massively parallel cDNA sequencing , or RNA - seq , has allowed many advances in the characterization and quantification of transcriptomes . Recently , several developments in RNA - seq methods have provided an even more complete characterization of RNA transcripts . These developments include improvements in transcription start site mapping , strand - specific measurements , gene fusion detection , small RNA characterization and detection of alternative splicing events . Ongoing developments promise further advances in the application of RNA - seq , particularly direct RNA sequencing and approaches that allow RNA quantification from very small amounts of cellular materials . APPLICATIONS OF NEXT - GENErATION SEQUENCING REVIEWS NATuRe RevIeWS | Genetics vOLume 12 | feBRuARy 2011 | 87 © 2011 Macmillan Publishers Limited . All rights reserved Semisuppressive PCR A PCR strategy that aims to reduce primer dimer accumulation by preferentially amplifying longer DNA fragments . products and to identify adjacent promoter regions that regulate the expression of each transcript . One of the first high - throughput TSS mapping methods was the cap analysis of gene expression ( CAGe ) approach , which was initially developed for Sanger sequencing 8 , 9 . This involved sequencing of cloned cDNA products derived from RNAs with intact 5 ′ ends ( for example , containing a 5 ′ cap structure ) . Although useful , the technology required high quantities of input RNA and generated only short reads ( ~ 20 nucleotides ) per TSS . These limitations prompted the adaptation of the CAGe approach for NGS platforms , which has resulted in the discovery of the unexpected complexity of TSS dis - tribution across genomes and in the regions surrounding individual promoters . methods that combine RNA - seq with CAGe include deepCAGe 10 , PeAT 11 , nanoCAGe and CAGescan 12 , which collectively resolve several technical challenges of the initial Sanger sequencing - based CAGe strategies ( TABLE 1 ) . first , nanoCAGe 12 now allows TSS mapping from total RNA quantities as small as 10 nanograms through the use of various amplifica - tion strategies . Second , the compatibility of PeAT and CAGescan with paired - end sequencing ( a capability that is enabled by platforms such as Illumina , but is lacking in others such as Helicos ) allows examination of the con - nectivity of TSSs with downstream regions and facilitates the assignment of identified TSSs to specific transcripts . In addition , paired - end sequencing partly alleviates the difficulty of aligning single short reads to repeat regions and thus allows a subset of repeat elements to be at least partially characterized by RNA - seq . However , there are several caveats of these NGS - based approaches . One is that no attempt has been made to examine whether the amplification and other manipulation steps that are carried out distort the result - ing view of how frequently each TSS is used . Spike - in experiments would be useful to address this issue . In addition , multiple difficulties were encountered during the development of protocols involving cDNA synthesis and amplification 12 . for example , researchers observed artefacts such as primer dimers that dominated sequenc - ing data sets and reduced effective coverage , prompting the use of semisuppressive PCR to reduce primer dimer frequency 12 . Thus , although these methods may be use - ful for qualitative applications , establishing and improv - ing their quantitative capabilities will probably require additional development . General limitations of RNA - based TSS mapping approaches include their dependence on cDNA syn - thesis or hybridization steps , the efficiency of which is dependent on RNA sequence and structure . In addition , RNA - based TSS mapping is challenging for short - lived transcripts such as primary microRNAs , which are tran - scribed generally at high levels but are scarce owing to their rapid degradation . These limitations may be partly alleviated when combined with other methods such as chromatin - based TSS prediction , which relies on detect - ing histone modifications that are indicative of active transcription 13 , 14 . Such integration may also be useful in light of the recent suggestion that post - transcriptional processing results in 5 ′ cap - like structures in RNA frag - ments 15 . Thus , relying solely on CAGe data for TSS map - ping may result in difficulties in separating transcription initiation events from RNA processing events . Strand - specific rNA - seq Transcriptomic studies in a range of species have revealed a pervasive presence of antisense transcription events 16 . Although these events were once considered to reflect biological or technical noise , it is now clear that antisense transcripts are functional and have vari - ous roles in both normal physiological states and disease states 16 . There is therefore an increasing interest in pro - filing transcriptomes at greater depths to fully character - ize sense and antisense transcription products . Standard RNA - seq approaches generally require double - stranded cDNA synthesis , which erases RNA strand information . In addition , during first - strand cDNA synthesis , spuri - ous second - strand cDNA artefacts can be introduced , owing to the DNA - dependent DNA polymerase ( DDDP ) activities of reverse transcriptases 17 – 19 , which can con - found sense versus antisense transcript determination 20 . Actinomycin D has been suggested as a potential agent to reduce DDDP activities of reverse transcriptases 18 , but the extent to which it is effective , and whether or not it introduces additional artefacts , has not been fully examined . To overcome these difficulties , several strate - gies for strand - specific analyses of transcriptomes have been developed . The strategies that have been developed to gener - ate strand - specific information generally rely on one of three approaches . The first involves the ligation of adaptors in a predetermined orientation to the ends of RNAs or to first - strand cDNA molecules 21 – 23 . The Table 1 | Next generation sequencing - based approaches for transcription start site mapping tss method RnA sequence data starting RnA Refs CAGE 5 ′ end of transcripts 50 μ g total RNA 9 DeepCAGE 5 ′ end of transcripts 10 ng total RNA 10 nanoCAGE 5 ′ end of transcripts 10 ng total RNA 12 CAGEscan 5 ′ end of transcripts and either 3 ′ end or internal RNA sequence 10 ng total RNA 12 PEAT 5 ′ end of transcripts paired with random reads along the RNA 150 μ g total RNA 11 CAGE , cap analysis of gene expression ; CAGEscan , paired read to combine 5 ′ CAGE with downstream sequence ; DeepCAGE , high - throughput CAGE sequencing ; nanoCAGE , low - quantity CAGE ; ng , nanograms ; PEAT , paired end analysis of transcription start sites ; TSS , transcription start site . R E V I E W S 88 | feBRuARy 2011 | vOLume 12 www . nature . com / reviews / genetics © 2011 Macmillan Publishers Limited . All rights reserved Spike pool Internal controls added to RNA samples , consisting of RNA elements of known sequence and composition . Paired - end reads A strategy involving sequencing of two different regions that are located apart from each other on the same DNA fragment . This strategy provides elevated physical coverage and alleviates several limitations of NGS platforms that arise because of their relatively short read length . known orientations of these adaptors are used as refer - ence points to obtain RNA strand information . A sec - ond approach is the direct sequencing of the first - strand cDNA products that are generated , either in solution 24 , 25 or on surfaces 26 . Last , a third approach is the selective chemical marking of the second - strand cDNA synthe - sis products or RNA 27 , 28 . These strategies have already begun to contribute to our understanding of transcrip - tomes , including mapping of translation states of RNAs ( for example , polysome profiling ) 29 and identification of novel promoter - associated RNAs 22 . A recent study that used the Saccharomyces cerevisiae genome as a reference compared the performance of sev - eral of these strategies , and the authors observed differ - ences in these methods with respect to their level of strand specificity , evenness of coverage , agreement with known annotations , library complexity ( for example , number of unique read start positions , which indicates the pro - tocols’ abilities to avoid amplification artefacts such as duplicate reads ) and ability to generate quantitative expression profiles 30 . However , in - depth comparative studies that characterize the biases and artefacts that are introduced by each of these approaches are still lacking , and scientists working with these data sets should be aware of several issues . first , given the tendency of reverse transcriptase to generate spurious second - strand cDNA products during first - strand cDNA synthesis 17 – 19 , it is not clear whether the approaches that rely on sequencing first - strand cDNA products ( either directly or by intra - or inter - molecular ligation ) are absolutely strand specific . The strand specificity of such approaches has been reported by quantifying the ratio of reads that map in the anti - sense orientation to the known , well - annotated genes , relative to the reads that map in the sense orientation . This investigation revealed that a small fraction of reads obtained with these approaches still align in the antisense orientation ; thus , these approaches may not be entirely strand - specific 30 . furthermore , cDNA products that contain both first - and second - strand cDNA products may not align properly to reference sequences . Given the incomplete annotations of sense and antisense tran - scripts in genomes , even in those of well - studied species such as S . cerevisiae , the true extent of strand specificity of these approaches should be carefully assessed . Ideally , such assessment should be performed with chemically synthesized RNA spike pools of defined sequence . Second , ligation tends to have sequence prefer - ences 31 , 32 . Thus , the approaches that rely on ligation may suffer from various representational biases . examples of such bias are found in transcriptome profiling 23 and ribosome profiling experiments 29 , in which extremely uneven coverage was seen for libraries prepared using ligation , compared with libraries prepared using enzy - matic 3 ′ polyadenylation 29 . Third , the in - solution or on - surface amplification step included in some of these approaches may introduce additional artefacts — for example , in the form of GC biases and dupli - cate reads 33 – 35 . examination of such effects revealed a duplicate read fraction in the range of 6 . 1 % to 94 . 1 % for standard and strand - specific Illumina RNA - seq strategies , and the existence of GC bias towards RNA templates with neutral GC content 23 . It is hoped that many of these limitations will be overcome by the sequencing technologies that are in development or with modifications and improvements to existing sequencing technologies 4 . Characterization of alternative splicing patterns Given the importance of alternative splicing patterns in development and the fact that 15 – 60 % of known disease - causing mutations affect splicing 36 , 37 , it will be crucial to catalogue the complete repertoire of splicing events and to understand how altered splicing patterns contribute to development , cell differentiation and human disease . Initial splice - site mapping studies using RNA sequencing - based approaches were limited by read length , which prevented the reliable alignment to the genome of the two independent exonic portions of each read , repre - senting the exon splicing event . Thus , initial RNA - seq - based studies of alternative splicing used computational strategies to compensate for this limitation . The refer - ence sequence used for alignment was supplemented with ‘artificial’ sequences that surround all possible splice junctions between the annotated exons of genes , allowing the reads to be aligned 38 – 41 . These approaches changed our view of human splicing , as more than 95 % of human multi - exon genes were found to be alternatively spliced , with ~ 110 , 000 novel splice sites per tissue 42 . By counting the number of reads mapping to each exon and spanning each splice junction , these approaches also allowed the splice efficiency of each junction to be determined and the levels of distinct isoforms to be quantified 43 , 44 . Improvements to current sequencing technologies now enable longer read lengths , allowing better map - ping of the reads to the alternatively spliced exons . This improvement comes from being able to partition the reads into multiple pieces and to align each piece inde - pendently to the genomes . In addition , approaches that involve paired - end reads now enable sequence informa - tion to be obtained from two points in a transcript with an estimated distance between the reads . As a result , it is now possible to search for splicing patterns without a requirement for prior knowledge of transcript anno - tations 45 , 46 ( FIG . 1 ) . examination of splicing patterns and transcript connectivity in an unbiased and genome - wide manner requires full - length transcript sequences to be obtained , which may be enabled in the future by emerging technologies 47 , 48 . Gene fusion detection RNA - seq combined with computational analyses analo - gous to the ones described above for splice - site detection can also be used to identify gene fusion events in dis - ease tissues , which has particular importance for cancer research 49 . Genomic DNA can be analysed with single - read and paired - end - read strategies for the detection of translocations and other genomic rearrangements 50 . However , RNA - seq may be preferable for identify - ing events that produce aberrant RNA species and therefore have a higher likelihood of being functional or causal in biological or disease settings 51 , 52 ( FIG . 2 ) . R E V I E W S NATuRe RevIeWS | Genetics vOLume 12 | feBRuARy 2011 | 89 © 2011 Macmillan Publishers Limited . All rights reserved (cid:48)(cid:67)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:52)(cid:71)(cid:88)(cid:75)(cid:71)(cid:89)(cid:85)(cid:2) (cid:94) (cid:2)(cid:41)(cid:71)(cid:80)(cid:71)(cid:86)(cid:75)(cid:69)(cid:85) (cid:43)(cid:85)(cid:81)(cid:72)(cid:81)(cid:84)(cid:79)(cid:2)(cid:5)(cid:20) (cid:19) (cid:20) (cid:21) (cid:22) (cid:23) (cid:24) (cid:19) (cid:21) (cid:23) (cid:24) (cid:19) (cid:20) (cid:21) (cid:22) (cid:23) (cid:24) (cid:19) (cid:21) (cid:23) (cid:24) (cid:19) (cid:20) (cid:21) (cid:22) (cid:23) (cid:24) (cid:19) (cid:20) (cid:21) (cid:22) (cid:23) (cid:24) (cid:47)(cid:67)(cid:82)(cid:82)(cid:75)(cid:80)(cid:73)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85)(cid:86)(cid:81)(cid:2)(cid:73)(cid:71)(cid:80)(cid:81)(cid:79)(cid:75)(cid:69)(cid:2)(cid:38)(cid:48)(cid:35) (cid:47)(cid:67)(cid:82)(cid:82)(cid:75)(cid:80)(cid:73)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85)(cid:86)(cid:81)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86)(cid:81)(cid:79)(cid:71) (cid:67)(cid:2) (cid:2)(cid:53)(cid:75)(cid:80)(cid:73)(cid:78)(cid:71)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85) (cid:68)(cid:2) (cid:2)(cid:50)(cid:67)(cid:75)(cid:84)(cid:71)(cid:70)(cid:15)(cid:71)(cid:80)(cid:70)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85) (cid:47)(cid:67)(cid:82)(cid:82)(cid:75)(cid:80)(cid:73)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85)(cid:86)(cid:81)(cid:2)(cid:73)(cid:71)(cid:80)(cid:81)(cid:79)(cid:75)(cid:69)(cid:2)(cid:38)(cid:48)(cid:35) (cid:47)(cid:67)(cid:82)(cid:82)(cid:75)(cid:80)(cid:73)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85)(cid:86)(cid:81)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86)(cid:81)(cid:79)(cid:71) (cid:43)(cid:85)(cid:81)(cid:72)(cid:81)(cid:84)(cid:79)(cid:2)(cid:5)(cid:19) (cid:43)(cid:85)(cid:81)(cid:72)(cid:81)(cid:84)(cid:79)(cid:2)(cid:5)(cid:19) (cid:43)(cid:85)(cid:81)(cid:72)(cid:81)(cid:84)(cid:79)(cid:2)(cid:5)(cid:20) (cid:19) (cid:20) (cid:21) (cid:22) (cid:23) (cid:24) (cid:19) (cid:20) (cid:21) (cid:22) (cid:23) (cid:24) furthermore , genomic DNA - based approaches cannot identify fusion events that are due to non - genomic fac - tors , such as trans - splicing 53 and read - through events between adjacent transcripts 51 , 54 . Paired - end RNA - seq can be particularly advantageous for fusion identifi - cation because of the increased physical coverage it offers . This approach has led to important biological findings in oncology 55 , 56 , offering potential targets for therapeutic modulation . The challenges faced in fusion detection are gen - erally in parallel with those for alternative splicing detection . In addition , RNA - seq - based analyses cannot detect fusion events that involve the exchange of the promoter of a gene with the coding sequence of another gene . furthermore , RNA - seq data include chimeric cDNA artefacts that are generated by template switching during reverse transcription and amplification 57 ( dis - cussed below ) , leading to false positives in gene fusion identification . These difficulties may be partly allevi - ated when long - read RNA sequencing technologies with sufficient throughput and sequencing performance become available 4 . Targeted approaches using rNA - seq Despite the increasing capabilities of NGS in terms of throughput and decreasing costs per data point , the expenditure necessary to obtain sufficient sequenc - ing coverage for several research and potential clinical applications is still prohibitive . Such applications include the characterization of low - abundance transcripts and genotyping to determine , for example , which alleles of the transcripts might be differentially expressed . In these scenarios , it may be preferable to enrich for the desired subset of transcripts , to minimize the overall cost of sequencing and maximize the number of samples that can be analysed . Target - enrichment strategies were originally devel - oped for genomic DNA resequencing 4 , 58 . many of these technologies have been used to capture the human exome from genomic DNA , given that a large fraction of disease - causing mutations are likely to be located in the protein - coding transcriptome . RNA - seq of poly ( A ) + RNA species offers a natural route for exome sequenc - ing without the use of enrichment strategies . The potential suitability of mRNA - seq data for the identifi - cation of nucleotide variations has been demonstrated recently by several studies 59 – 61 . However , these studies also underscored some challenges — for example , the high sequencing depth required to sufficiently cover low - abundance transcripts . Slight modifications of the genomic DNA - enrichment strategies for cDNA applications have allowed the devel - opment of targeted RNA - seq ( FIG . 3 ) . Targeted RNA - seq approaches have been used to detect fusion transcripts , allele - specific expression , mutations and RNA - editing events in a subset of transcripts 62 – 64 . Targeted RNA - seq strategies currently require longer sample preparation steps and higher input RNA and cDNA quantities than do other RNA - seq approaches , owing to the additional probe or microarray preparation and target - selection steps . furthermore , capture efficiency usually differs between target regions depending on hybridization effi - ciency and other factors . Simplification of this process and improvements in capture efficiency are desirable for better experimental outcomes . Small rNA profiling The impact of NGS technologies on sRNA discovery and characterization has been particularly noteworthy . These studies have been reviewed extensively by oth - ers ( for example , see REF . 65 ) , so we do not review this topic in depth here but provide a brief summary for completeness . most initial sRNA - discovery studies used pyro - sequencing 66 , 67 . Subsequently , the use of other NGS platforms with higher throughput has resulted in genome - wide surveys and the discovery of an ever - growing number of sRNA species 15 , 68 , 69 . Because NGS sample preparation strategies for ‘longer’ RNAs Figure 1 | RnA - seq for detection of alternative splicing events . a | Sequence reads are mapped to genomic DNA or to a transcriptome reference to detect alternative isoforms of an RNA transcript . Mapping is based simply on read counts to each exon and reads that span the exonic boundaries . One infers the absence of the genomic exon in the transcript by virtue of no reads mapping to the genomic location . b | Paired sequence reads provide additional information about exonic splicing events , as demonstrated by matching the first read in one exon and placing the second read in the downstream exon , creating a map of the transcript structure . R E V I E W S 90 | feBRuARy 2011 | vOLume 12 www . nature . com / reviews / genetics © 2011 Macmillan Publishers Limited . All rights reserved (cid:48)(cid:67)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:52)(cid:71)(cid:88)(cid:75)(cid:71)(cid:89)(cid:85)(cid:2) (cid:94) (cid:2)(cid:41)(cid:71)(cid:80)(cid:71)(cid:86)(cid:75)(cid:69)(cid:85) (cid:35)(cid:36)(cid:46)(cid:19) (cid:2)(cid:73)(cid:71)(cid:80)(cid:71)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86) (cid:36)(cid:37)(cid:52) (cid:2)(cid:73)(cid:71)(cid:80)(cid:71)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86) (cid:35)(cid:36)(cid:46)(cid:19) (cid:2)(cid:73)(cid:71)(cid:80)(cid:71)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86) (cid:67) (cid:68) (cid:36)(cid:37)(cid:52) (cid:2)(cid:73)(cid:71)(cid:80)(cid:71)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86) (cid:36)(cid:37)(cid:52)(cid:115)(cid:35)(cid:36)(cid:46) (cid:2)(cid:72)(cid:87)(cid:85)(cid:75)(cid:81)(cid:80) (cid:23)(cid:16)(cid:26)(cid:15)(cid:77)(cid:68)(cid:2)(cid:79)(cid:52)(cid:48)(cid:35) (cid:24)(cid:16)(cid:27)(cid:15)(cid:77)(cid:68)(cid:2)(cid:79)(cid:52)(cid:48)(cid:35) (cid:39)(cid:90)(cid:81)(cid:80)(cid:85)(cid:2)(cid:19)(cid:115)(cid:19)(cid:22) (cid:39)(cid:90)(cid:81)(cid:80)(cid:85)(cid:2)(cid:20)(cid:115)(cid:19)(cid:19) (cid:69) (cid:42)(cid:55)(cid:38)(cid:36)(cid:55)(cid:38)(cid:42)(cid:55)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:55)(cid:36)(cid:38)(cid:55)(cid:42)(cid:38)(cid:36)(cid:38)(cid:38)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:42)(cid:42)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:38)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:42)(cid:42)(cid:55)(cid:36)(cid:55)(cid:55)(cid:55)(cid:55) (cid:36)(cid:37)(cid:52)(cid:2) (cid:36)(cid:42)(cid:42)(cid:38)(cid:36)(cid:55)(cid:42)(cid:42)(cid:42)(cid:42)(cid:42)(cid:55)(cid:38)(cid:38)(cid:36)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:38)(cid:36)(cid:36)(cid:55)(cid:42)(cid:55)(cid:55)(cid:55)(cid:55)(cid:55)(cid:42)(cid:55)(cid:42)(cid:42)(cid:36)(cid:36)(cid:38)(cid:36)(cid:55)(cid:42)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:42)(cid:38)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42) (cid:35)(cid:36)(cid:46)(cid:19)(cid:2) (cid:42)(cid:55)(cid:38)(cid:36)(cid:55)(cid:38)(cid:42)(cid:55)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:42)(cid:38)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42) (cid:36)(cid:37)(cid:52) (cid:115) (cid:35)(cid:36)(cid:46) (cid:2)(cid:72)(cid:87)(cid:85)(cid:75)(cid:81)(cid:80)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86)(cid:2) (cid:42)(cid:55)(cid:38)(cid:36)(cid:55)(cid:16)(cid:42)(cid:55)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:16)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:16)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:3)(cid:3)(cid:55)(cid:38)(cid:36)(cid:55)(cid:16)(cid:42)(cid:55)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:16)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:55)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:55)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:16)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:16)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:36)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:42)(cid:38)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:36)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:55)(cid:42)(cid:42)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:16)(cid:16)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:16)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:55)(cid:42)(cid:16)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:36)(cid:55)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:16)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:55)(cid:55)(cid:36)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:36)(cid:42)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:16)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:16)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:16)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:36)(cid:55)(cid:16)(cid:36)(cid:16)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:16)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:16)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:36)(cid:42)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:36)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:16)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:16)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:42)(cid:55)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:16)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:16)(cid:38)(cid:16)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:55)(cid:38)(cid:36)(cid:36)(cid:36)(cid:16)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:38)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:38)(cid:36)(cid:36)(cid:36)(cid:16)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:16)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:42)(cid:38)(cid:38)(cid:55)(cid:38)(cid:36)(cid:42)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:36)(cid:36)(cid:36)(cid:36)(cid:42)(cid:38)(cid:38)(cid:38)(cid:55)(cid:55)(cid:38)(cid:36)(cid:42)(cid:16)(cid:42)(cid:42)(cid:38)(cid:38)(cid:36)(cid:42)(cid:55)(cid:36)(cid:42)(cid:38)(cid:36)(cid:55)(cid:38)(cid:55)(cid:42)(cid:36)(cid:38)(cid:55)(cid:55)(cid:55)(cid:42)(cid:36)(cid:42)(cid:3) ( > 200 nucleotides ) are not suitable for sRNAs , such as reverse transcription with random priming ( because this way of priming cDNA synthesis from short RNA species yields even shorter cDNA species that are not long enough for efficient alignment ) , modified preparation strategies were developed 70 – 72 . One important limitation of the current RNA - seq - based approaches for studying sRNAs is their inability to provide an absolutely quantitative view of these tran - scripts . It has recently become clear that , although the NGS - based sRNA - profiling approaches can be used for differential expression analyses , the number of reads obtained per sRNA does not necessarily correlate with their actual abundance 73 , 74 . This discrepancy seems to be due to biases that are introduced during the sample preparation and sequencing steps . Whether emerging technologies can improve sRNA quantification remains to be seen . Direct rNA sequencing cDNA synthesis and other RNA manipulations limit some RNA - seq applications . As noted above , most current RNA - seq methods rely on cDNA synthesis and a range of subsequent manipulation steps , which places limitations on the current approaches for some applications . for example , as we have discussed , the generation of spurious second - strand cDNAs can present difficulties for strand - specific RNA - seq . Strand - specific libraries can also be prepared to avoid this problem ( discussed above ) , but the approaches that use RNA – RNA ligation are laborious to construct . Another limitation imposed by cDNA synthesis is tem - plate switching 75 – 77 . During the process of reverse tran - scription , the nascent cDNA that is being synthesized can sometimes dissociate from the template RNA and re - anneal to a different stretch of RNA with a sequence similar to the initial template , generating artefactual Figure 2 | Use of RnA - seq for BCR – ABL fusion gene detection . a | Breakpoint cluster region ( BCR ) and ABL1 gene transcripts . b | BCR – ABL fusion gene transcript . c | Sequence reads mapping across the BCR – ABL fusion gene site demonstrating the ability to accurately identify the site of gene fusion . The data were derived from RNA - seq analysis 25 of the K562 transcriptome using the HeliScope ( the raw data files are available at the University of California Santa Cruz Genome Browser and the Helicos Technology Center ) . R E V I E W S NATuRe RevIeWS | Genetics vOLume 12 | feBRuARy 2011 | 91 © 2011 Macmillan Publishers Limited . All rights reserved (cid:68) (cid:67) (cid:50)(cid:81)(cid:78)(cid:91)(cid:2)(cid:10)(cid:35)(cid:11) (cid:13) (cid:2)(cid:52)(cid:48)(cid:35) (cid:72)(cid:84)(cid:67)(cid:73)(cid:79)(cid:71)(cid:80)(cid:86) (cid:38)(cid:81)(cid:87)(cid:68)(cid:78)(cid:71)(cid:15)(cid:85)(cid:86)(cid:84)(cid:67)(cid:80)(cid:70)(cid:71)(cid:70)(cid:69)(cid:38)(cid:48)(cid:35)(cid:2)(cid:69)(cid:81)(cid:80)(cid:88)(cid:71)(cid:84)(cid:85)(cid:75)(cid:81)(cid:80) (cid:39)(cid:78)(cid:87)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:81)(cid:72)(cid:2)(cid:85)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:71)(cid:15)(cid:2)(cid:85)(cid:82)(cid:71)(cid:69)(cid:75)(cid:558)(cid:69)(cid:2)(cid:69)(cid:38)(cid:48)(cid:35)(cid:85) (cid:49)(cid:80)(cid:15)(cid:85)(cid:87)(cid:84)(cid:72)(cid:67)(cid:69)(cid:71)(cid:2)(cid:86)(cid:67)(cid:84)(cid:73)(cid:71)(cid:86)(cid:2)(cid:85)(cid:71)(cid:78)(cid:71)(cid:69)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:67)(cid:80)(cid:70)(cid:2)(cid:85)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:75)(cid:80)(cid:73) (cid:53)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:75)(cid:80)(cid:73)(cid:2)(cid:85)(cid:87)(cid:84)(cid:72)(cid:67)(cid:69)(cid:71)(cid:2)(cid:89)(cid:75)(cid:86)(cid:74)(cid:2)(cid:78)(cid:81)(cid:69)(cid:87)(cid:85)(cid:15)(cid:85)(cid:82)(cid:71)(cid:69)(cid:75)(cid:558)(cid:69)(cid:2)(cid:82)(cid:84)(cid:75)(cid:79)(cid:71)(cid:84)(cid:85) (cid:48)(cid:75)(cid:79)(cid:68)(cid:78)(cid:71)(cid:41)(cid:71)(cid:80)(cid:2) (cid:85)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:71)(cid:69)(cid:67)(cid:82)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:67)(cid:84)(cid:84)(cid:67)(cid:91) (cid:53)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:71)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85) (cid:53)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:71)(cid:2)(cid:84)(cid:71)(cid:67)(cid:70)(cid:85) (cid:38)(cid:75)(cid:84)(cid:71)(cid:69)(cid:86)(cid:2)(cid:52)(cid:48)(cid:35)(cid:2)(cid:85)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:75)(cid:80)(cid:73) (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:114)(cid:2)(cid:35)(cid:70)(cid:67)(cid:82)(cid:86)(cid:71)(cid:84)(cid:2)(cid:78)(cid:75)(cid:73)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:114)(cid:2)(cid:50)(cid:37)(cid:52)(cid:2)(cid:67)(cid:79)(cid:82)(cid:78)(cid:75)(cid:558)(cid:69)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:114)(cid:2)(cid:53)(cid:75)(cid:92)(cid:71)(cid:2)(cid:85)(cid:71)(cid:78)(cid:71)(cid:69)(cid:86)(cid:75)(cid:81)(cid:80) (cid:50)(cid:81)(cid:78)(cid:91)(cid:10)(cid:35)(cid:11) (cid:13) (cid:2)(cid:52)(cid:48)(cid:35) (cid:84)(cid:67)(cid:80)(cid:70)(cid:81)(cid:79)(cid:2)(cid:74)(cid:71)(cid:90)(cid:67)(cid:79)(cid:71)(cid:84)(cid:85) (cid:43)(cid:85)(cid:81)(cid:78)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:81)(cid:72)(cid:2)(cid:69)(cid:38)(cid:48)(cid:35)(cid:2)(cid:67)(cid:80)(cid:70)(cid:2)(cid:68)(cid:67)(cid:75)(cid:86)(cid:85) (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:38)(cid:81)(cid:87)(cid:68)(cid:78)(cid:71)(cid:15)(cid:85)(cid:86)(cid:84)(cid:67)(cid:80)(cid:70)(cid:71)(cid:70)(cid:69)(cid:38)(cid:48)(cid:35)(cid:2)(cid:69)(cid:81)(cid:80)(cid:88)(cid:71)(cid:84)(cid:85)(cid:75)(cid:81)(cid:80) (cid:52)(cid:48)(cid:35)(cid:2)(cid:85)(cid:74)(cid:71)(cid:67)(cid:84)(cid:75)(cid:80)(cid:73) (cid:52)(cid:48)(cid:35)(cid:2)(cid:85)(cid:74)(cid:71)(cid:67)(cid:84)(cid:75)(cid:80)(cid:73) (cid:70) (cid:69) (cid:40)(cid:84)(cid:67)(cid:73)(cid:79)(cid:71)(cid:80)(cid:86)(cid:71)(cid:70)(cid:2)(cid:52)(cid:48)(cid:35) (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:50)(cid:81)(cid:78)(cid:91)(cid:2)(cid:10)(cid:35)(cid:11) (cid:13) (cid:2)(cid:52)(cid:48)(cid:35) (cid:84)(cid:67)(cid:80)(cid:70)(cid:81)(cid:79)(cid:2)(cid:74)(cid:71)(cid:90)(cid:67)(cid:79)(cid:71)(cid:84)(cid:85) (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:38)(cid:81)(cid:87)(cid:68)(cid:78)(cid:71)(cid:15)(cid:85)(cid:86)(cid:84)(cid:67)(cid:80)(cid:70)(cid:71)(cid:70)(cid:69)(cid:38)(cid:48)(cid:35)(cid:2)(cid:69)(cid:81)(cid:80)(cid:88)(cid:71)(cid:84)(cid:85)(cid:75)(cid:81)(cid:80) (cid:114)(cid:2)(cid:38)(cid:71)(cid:80)(cid:67)(cid:86)(cid:87)(cid:84)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:114)(cid:2)(cid:35)(cid:70)(cid:70)(cid:75)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:81)(cid:72)(cid:2)(cid:82)(cid:67)(cid:70)(cid:78)(cid:81)(cid:69)(cid:77)(cid:2)(cid:82)(cid:84)(cid:81)(cid:68)(cid:71)(cid:85) (cid:35)(cid:79)(cid:82)(cid:78)(cid:75)(cid:558)(cid:69)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:81)(cid:72)(cid:2)(cid:84)(cid:71)(cid:73)(cid:75)(cid:81)(cid:80)(cid:2) (cid:81)(cid:72)(cid:2)(cid:75)(cid:80)(cid:86)(cid:71)(cid:84)(cid:71)(cid:85)(cid:86)(cid:2)(cid:75)(cid:80)(cid:2)(cid:69)(cid:38)(cid:48)(cid:35) (cid:114)(cid:2)(cid:35)(cid:70)(cid:67)(cid:82)(cid:86)(cid:71)(cid:84)(cid:2)(cid:78)(cid:75)(cid:73)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:114)(cid:2)(cid:50)(cid:37)(cid:52)(cid:2)(cid:67)(cid:79)(cid:82)(cid:78)(cid:75)(cid:558)(cid:69)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:114)(cid:2)(cid:53)(cid:75)(cid:92)(cid:71)(cid:2)(cid:85)(cid:71)(cid:78)(cid:71)(cid:69)(cid:86)(cid:75)(cid:81)(cid:80) (cid:35)(cid:73)(cid:75)(cid:78)(cid:71)(cid:80)(cid:86)(cid:2)(cid:53)(cid:87)(cid:84)(cid:71)(cid:53)(cid:71)(cid:78)(cid:71)(cid:69)(cid:86)(cid:2)(cid:114)(cid:2)(cid:35)(cid:79)(cid:82)(cid:78)(cid:75)(cid:558)(cid:69)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:114)(cid:2)(cid:38)(cid:71)(cid:80)(cid:67)(cid:86)(cid:87)(cid:84)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:114)(cid:2)(cid:13)(cid:2)(cid:19)(cid:25)(cid:18)(cid:15)(cid:80)(cid:86)(cid:2)(cid:52)(cid:48)(cid:35)(cid:2)(cid:68)(cid:67)(cid:75)(cid:86)(cid:85) (cid:114)(cid:2)(cid:52)(cid:71)(cid:79)(cid:81)(cid:88)(cid:67)(cid:78)(cid:2)(cid:81)(cid:72)(cid:2)(cid:68)(cid:67)(cid:75)(cid:86)(cid:85)(cid:114)(cid:2)(cid:53)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:71)(cid:2)(cid:2)(cid:2)(cid:2)(cid:67)(cid:79)(cid:82)(cid:78)(cid:75)(cid:558)(cid:69)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80) (cid:13)(cid:2)(cid:50)(cid:81)(cid:78)(cid:91)(cid:79)(cid:71)(cid:84)(cid:67)(cid:85)(cid:71)(cid:13)(cid:2)(cid:70)(cid:48)(cid:54)(cid:50)(cid:85)(cid:13)(cid:2)(cid:46)(cid:75)(cid:73)(cid:67)(cid:85)(cid:71) (cid:13) (cid:48)(cid:67)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:52)(cid:71)(cid:88)(cid:75)(cid:71)(cid:89)(cid:85)(cid:2) (cid:94) (cid:2)(cid:41)(cid:71)(cid:80)(cid:71)(cid:86)(cid:75)(cid:69)(cid:85) (cid:114)(cid:2)(cid:35)(cid:70)(cid:70)(cid:75)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:81)(cid:72)(cid:2)(cid:37)(cid:49)(cid:54)(cid:2)(cid:38)(cid:48)(cid:35)(cid:114)(cid:2)(cid:42)(cid:91)(cid:68)(cid:84)(cid:75)(cid:70)(cid:75)(cid:92)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80) R E V I E W S 92 | feBRuARy 2011 | vOLume 12 www . nature . com / reviews / genetics © 2011 Macmillan Publishers Limited . All rights reserved chimeric cDNAs . Template switching may cause prob - lems in the identification of exon – intron boundaries and true chimeric transcripts . Reverse transcriptases can also synthesize cDNA in a primer - independent manner , which is thought to be caused by self priming arising from the RNA secondary structure . This results in the generation of random cDNA synthesis . furthermore , reverse transcriptases have lower fidelity compared to other polymerases owing to their lack of proofreading mechanisms 78 , 79 , and they have variable RNA to cDNA conversion efficiency depending on the experimental conditions . In addition to their requirement for cDNA synthesis , current RNA - seq approaches can present other difficul - ties . first , the RNA - seq signal across transcripts tends to show non - uniformity of coverage , which may be a result of biases introduced during various steps , such as priming with random hexamers 80 , 81 , cDNA synthe - sis , ligation 31 , 32 , amplification 35 and sequencing 33 – 35 , 82 . Second , commonly used RNA - seq strategies can result in transcript - length bias because of the multi - ple fragmentation and RNA or cDNA size - selection steps they use 83 . This bias may result in complications for downstream analyses 84 . Third , quantification of transcripts with RNA - seq requires consideration of read mapping uncertainty ( owing to sequencing error rates , repetitive elements , incomplete genome sequence and inaccuracies in transcript annotations ) 85 and normalization of the number of reads mapping to each transcript , based on transcript length . Despite improvements in sequencing methods and bioinfor - matics advances allowing de novo construction of transcriptomes 86 , 87 , the existing approaches are often not sufficient to detect certain transcripts and / or cover their entire length . Together with the uncertainty regarding transcript boundaries and length because of events such as alternative splicing , polyadenyla - tion sites and promoter usage , the required length - normalization step is a potential source of errors for quantitative applications . fourth , RNA - seq strategies often involve a poly ( A ) + mRNA - enrichment step . Polyadenylation of transcripts also takes place dur - ing transcript degradation steps , and thus poly ( A ) + - enrichment steps may also enrich for RNA degradation products of RNA polymerase I transcripts and other RNAs 88 . Direct sequencing of RNAs . The limitations of current RNA - seq approaches discussed above might be at least partly alleviated by emerging RNA analysis technolo - gies , including DRS , that substantially alter the method of RNA characterization . DRS currently requires single - molecule sequencing capabilities , as the ampli - fication of RNA molecules directly without cDNA conversion has not been examined . Although RNA - dependent RNA polymerases do exist 89 , the extent to which they can be adapted to the amplification - based next - generation sequencing technologies is unknown at present . The first massively parallel DRS approach was recently developed using the Helicos single - molecule sequencing platform 7 , 90 , 91 ( FIG . 4 ) . It relies on hybridi - zation of several femtomoles of 3 ′ - polyadenylated RNA templates to single channels of poly ( dT ) - coated sequencing surfaces , followed by sequencing by synthesis . This approach can select and sequence poly ( A ) + RNA from total RNA or cellular lysates , with sequence data being derived from regions immedi - ately upstream of the polyadenylation sites 7 . Thus , the technology offers a path to obtain gene expression profiles and map polyadenylation sites in a quantita - tive and genome - wide manner . RNA species that lack natural poly ( A ) tails can be polyadenylated in vitro and analysed with DRS . The development of DRS approaches that are free from cDNA synthesis artefacts such as template switching and spurious second - strand synthesis pro - vides potential improvements for applications such as the surveying of strand - specific transcription . furthermore , DRS requires only femtomole or atto - mole levels of input RNA , depending on the applica - tion , and involves relatively simple sample preparation . DRS - type technologies may therefore be advantageous for applications that are challenging for current cDNA - based methodologies , such as experiments that yield subnanogram - level RNA ( discussed below ) , archival specimens or short RNA species , which cannot be easily converted to cDNA . furthermore , unlike cDNA - based approaches , which require different strategies for the analysis of short and longer RNA species , DRS sample preparation involving polyadenylation can be applied to any RNA species , thus allowing both short and long RNAs to be observed in a single experiment . DRS may in the future also simplify targeted RNA - seq by ena - bling the integration of target selection and sequencing steps ( FIG . 3d ) . Such integration may reduce the sample preparation steps to only nucleic acid fragmentation , and may minimize costs as well as the quantity of input nucleic acid required . A key challenge for DRS is to generate the multi - million - level read quantities that are required for many RNA applications , particularly quantification , and to further reduce error rates and input RNA quantities through alterations to the sequencing chemistry and template - capture steps . DRS may also not solve all of the RNA - seq limitations listed above — including , for example , the issues of degradation products being cap - tured during poly ( A ) + RNA selection . furthermore , the combination of paired - end approaches with DRS and longer read lengths is needed for various applica - tions discussed above , including studies focusing on the identification of 5 ′ ( for example , CAGe - type TSS mapping ) and 3 ′ boundaries of RNA species . Figure 3 | Alternative methods for targeted RnA - seq . a | Using poly ( A ) + RNA converted to double - stranded cDNA the Agilent SureSelect method uses RNA probes to enrich selected cDNA 62 . b | A custom NimbleGen array may allow selection of cDNAs of interest . c | The generation of DNA molecules with sequence - specific complementary targeting sites allows the targeting of cDNAs 63 , 64 . d | Helicos sequencing surfaces containing target - specific oligonucleotides can be used to select desired RNA , DNA and cDNA species and sequence regions of interest in a single step . nt , nucleotide . ◀ R E V I E W S NATuRe RevIeWS | Genetics vOLume 12 | feBRuARy 2011 | 93 © 2011 Macmillan Publishers Limited . All rights reserved (cid:48)(cid:67)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:52)(cid:71)(cid:88)(cid:75)(cid:71)(cid:89)(cid:85)(cid:2) (cid:94) (cid:2)(cid:41)(cid:71)(cid:80)(cid:71)(cid:86)(cid:75)(cid:69)(cid:85) (cid:43)(cid:79)(cid:67)(cid:73)(cid:71)(cid:86)(cid:71)(cid:79)(cid:82)(cid:78)(cid:67)(cid:86)(cid:71)(cid:85)(cid:2) (cid:3) (cid:40)(cid:75)(cid:78)(cid:78)(cid:2)(cid:67)(cid:80)(cid:70)(cid:2)(cid:78)(cid:81)(cid:69)(cid:77) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:55) (cid:55) (cid:41)(cid:37) (cid:37)(cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:35) (cid:40) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:41) (cid:23) ′ (cid:23) ′ (cid:40) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:37) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:40) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:70)(cid:35) (cid:37) (cid:41) (cid:35) (cid:37)(cid:41) (cid:37)(cid:55) (cid:35) (cid:35) (cid:35) (cid:35)(cid:35)(cid:35) (cid:55) (cid:55) (cid:41)(cid:37) (cid:37)(cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:35) (cid:40) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:41) (cid:23) ′ (cid:23) ′ (cid:40) (cid:35)(cid:35) (cid:35)(cid:35)(cid:35)(cid:35) (cid:37) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:54) (cid:40) (cid:35)(cid:35)(cid:35)(cid:35) (cid:35)(cid:35) (cid:70)(cid:35) (cid:37) (cid:41) (cid:35) (cid:37)(cid:41) (cid:37)(cid:55) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:55) (cid:55) (cid:41)(cid:37) (cid:37) (cid:37)(cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:35) (cid:40) (cid:37) (cid:40) (cid:37) (cid:40) (cid:37) (cid:40) (cid:37) (cid:40) (cid:37) (cid:40) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:41) (cid:23) ′ (cid:23) ′ (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:37) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:70)(cid:35) (cid:37) (cid:41) (cid:35) (cid:37)(cid:41) (cid:37)(cid:55) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:55) (cid:55) (cid:41)(cid:37) (cid:37) (cid:37)(cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:35) (cid:40) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:41) (cid:23) ′ (cid:23) ′ (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:37) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:70)(cid:35) (cid:37) (cid:41) (cid:35) (cid:37)(cid:41) (cid:37)(cid:55) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:55) (cid:55) (cid:41)(cid:37) (cid:37) (cid:37) (cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:35) (cid:40) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:41) (cid:23) ′ (cid:23) ′ (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:37) (cid:41) (cid:55) (cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:70)(cid:35) (cid:37) (cid:41) (cid:35) (cid:37) (cid:41) (cid:37)(cid:55) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:55) (cid:55) (cid:41)(cid:37) (cid:37) (cid:37)(cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:54) (cid:54)(cid:54)(cid:41) (cid:23) ′ (cid:23) ′ (cid:35)(cid:35) (cid:35) (cid:35)(cid:35)(cid:35) (cid:37) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:70)(cid:35) (cid:37) (cid:41) (cid:35) (cid:37)(cid:41) (cid:37)(cid:55) (cid:40) (cid:37)(cid:78)(cid:71)(cid:67)(cid:88)(cid:71) (cid:37)(cid:78)(cid:71)(cid:67)(cid:88)(cid:71) (cid:57)(cid:67)(cid:85)(cid:74) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:35) (cid:55) (cid:55) (cid:41)(cid:37) (cid:37)(cid:35) (cid:70)(cid:35) (cid:54)(cid:54) (cid:54) (cid:54) (cid:54)(cid:54) (cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54) (cid:23) ′ (cid:23) ′ (cid:40) (cid:40) (cid:40) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:37) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:70)(cid:35)(cid:41) (cid:35) (cid:37)(cid:41) (cid:37)(cid:55) (cid:53)(cid:91)(cid:80)(cid:86)(cid:74)(cid:71)(cid:85)(cid:75)(cid:92)(cid:71) (cid:43)(cid:79)(cid:67)(cid:73)(cid:71) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:55) (cid:55) (cid:41)(cid:37) (cid:37)(cid:35) (cid:35) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:23) ′ (cid:23) ′ (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:37) (cid:41) (cid:41) (cid:55)(cid:35) (cid:55)(cid:37) (cid:70)(cid:35) (cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:54) (cid:54)(cid:54) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:70)(cid:35) (cid:41) (cid:35) (cid:37) (cid:37) (cid:41) (cid:37)(cid:55) (cid:40)(cid:78)(cid:81)(cid:89)(cid:2)(cid:69)(cid:71)(cid:78)(cid:78)(cid:2)(cid:69)(cid:67)(cid:82)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:81)(cid:72)(cid:2)(cid:21) ′ (cid:15)(cid:68)(cid:78)(cid:81)(cid:69)(cid:77)(cid:71)(cid:70)(cid:2)(cid:52)(cid:48)(cid:35)(cid:2)(cid:86)(cid:71)(cid:79)(cid:82)(cid:78)(cid:67)(cid:86)(cid:71)(cid:85)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:40)(cid:78)(cid:81)(cid:89)(cid:2)(cid:69)(cid:71)(cid:78)(cid:78) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:23) ′ (cid:54)(cid:54)(cid:54)(cid:54)(cid:54)(cid:54) (cid:23) ′ (cid:23) ′ (cid:23) ′ (cid:67) (cid:68) (cid:69) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:70)(cid:35) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:70)(cid:35) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:35)(cid:70)(cid:35) R E V I E W S 94 | feBRuARy 2011 | vOLume 12 www . nature . com / reviews / genetics © 2011 Macmillan Publishers Limited . All rights reserved Laser capture microdissection ( Often abbreviated to LCM . ) A method allowing cells of interest that are chosen by the operator using a microscope to be specifically captured from heterogeneous tissue samples . The isolated cells can be used for various analyses including of protein and nucleic acid . Profiling low - quantity rNA samples Biological specimens ( such as tissue and body fluids ) are generally heterogeneous , being a complex mixture of multiple cell types . The need to specifically select and study particular cells is clear , but the implementa - tion of this task is not straightforward . Several tools now allow selection of specific cell types , such as flow - assisted cell sorting ( fACS ) , laser - capture microdissection ( LCm ) 92 , serial dilution , specialized microfluidic devices 93 and micromanipulation . In addition , methods for high - quality RNA isolation from small quantities of cells are also available . The main limitation prevent - ing reliable , global profiling of minute RNA quantities has been the incompatibility of high - throughput RNA profiling approaches with low - quantity RNA samples . The absence of such methods has slowed our progress in a range of areas , such as forensics , stem cell biology , metagenomics and plant biology . The effects of this limitation are perhaps most acutely felt in research into cancer and other diseases , as samples obtained from patients are generally limited in quantity ; the transition between findings from molecular profiling studies and technologies for use in clinical research and molecular diagnostics is being held back , slowing our progress towards personalized medicine . Strategies that can pro - vide a comprehensive and bias - free view of transcrip - tomes using picogram quantities of input RNA would therefore stimulate great advances in a range of areas . Methods for small quantities of RNA . The analysis of low - quantity RNA samples with global microarray and sequencing technologies has traditionally required one or more amplification step ( s ) to obtain sufficient nucleic acid material for subsequent detection . Since the early 1990s , several nucleic acid amplification strat - egies for low - quantity RNA applications have been developed , such as ligation - mediated PCR 94 , multiple displacement amplification ( mDA ) 95 , single - primer isothermal amplification 96 and in vitro transcription ( IvT ) - based linear amplification 97 . The ideal ampli - fication method should provide accurate sequences with a low or zero error rate , be reproducible , produce high levels of amplification to provide the quantities of nucleic acid needed , be applicable for nucleic acids from a wide array of species , and preserve the repre - sentation of the distinct RNA molecules in the original sample . To what extent the current methods meet these criteria is not clear . Studies performed with microarray - based measurements suggest that amplification intro - duces variability and discrepancies , especially for middle - and low - abundance transcripts and as input RNA quantity is lowered further 98 . Sequencing - based low - quantity RNA profiling is relatively new . A recently reported mRNA - seq method relies on double PCR amplification steps and can be used to profile the transcriptomes of single oocytes 40 . It was observed , however , that the reproducibility of such low - quantity RNA - seq approaches may be negatively affected owing to stochastic amplification biases that may result in the drop - out of some RNA species and preferential amplification of others 23 . Such outcomes can lead to , for instance , duplicate reads and reduced quantification power . Emerging technologies . A number of both hybridi - zation - and sequencing - based technologies are now emerging that may allow reliable transcriptome pro - files to be obtained from minute cell quantities . On the sequencing side , nanoCAGe 12 now allows TSS map - ping from 10 nanograms of total RNA through the use of various amplification strategies . Amplification - free RNA - seq approaches have recently been developed that minimize the quantity of input RNA required . One approach involves the sequencing of first - strand cDNA products from as little as ~ 500 picograms of RNA , with priming carried out in solution with oligo - dT or ran - dom hexamers 24 , 25 . Another approach involves the use of poly ( dT ) primers on sequencing surfaces to select for poly ( A ) + mRNA from cellular lysates , followed by on - surface first - strand cDNA synthesis and sequencing 26 . This approach allows reproducible gene expression profiles to be obtained from ~ 1 , 000 cells and elimi - nates RNA loss during the RNA isolation steps , which may be particularly important as the input cell quan - tity is reduced . As described above , DRS eliminates the cDNA synthesis stage and requires only a few fem - tomoles of RNAs containing natural poly ( A ) tails or RNAs polyadenylated in vitro . It is also conceivable that microfluidic capabilities could be combined with DRS for single - cell applications ( FIG . 5a ) . Hybridization - based methodologies are also pro - viding promise for working with very small quantities of RNA . The NanoString nCounter System provides an alternative method for RNA quantification without the requirement for cDNA synthesis , and it relies on the generation of target - specific probes ( FIG . 5b ) . The probe mixture is hybridized to RNA samples in solu - tion , followed by the immobilization of probe – RNA duplexes on surfaces and single - molecule imaging to identify and count individual transcripts 99 . In principle , the system can detect up to 16 , 384 transcripts simul - taneously . This approach requires ~ 100 nanograms of RNA or 2000 – 5 , 000 cells 100 , but optimization of the probe hybridization and surface immobilization steps may further reduce input RNA quantity . Figure 4 | Direct RnA sequencing using the Helicos approach . a | RNA that is polyadenylated and 3 ′ deoxy - blocked with poly ( A ) polymerase is captured on poly ( dT ) - coated surfaces . A ‘fill - and - lock’ step is performed , in which the ‘fill’ step is performed with natural thymidine and polymerase , and the ‘lock’ step is performed with fluorescently labelled A , C and G Virtual Terminator ( VT ) nucleotides 104 and polymerase . This step corrects for any misalignments that may be present in poly ( A ) and poly ( T ) duplexes , and ensures that the sequencing starts in the RNA template rather than the polyadenylated tail . b | Imaging is performed to locate the positions of the templates . Then , chemical cleavage of the dye – nucleotide linker is performed to release the dye and prepare the templates for nucleotide incorporation . c | Incubation of this surface with one labelled nucleotide ( C - VT is shown as an example ) and a polymerase mixture is carried out . After this step , imaging is performed to locate the templates that have incorporated the nucleotide . Chemical cleavage of the dye allows the surface and DNA templates to be ready for the next nucleotide - addition cycle . Nucleotides are added in the C , T , A , G order for 120 total cycles ( 30 additions of each nucleotide ) . ◀ R E V I E W S NATuRe RevIeWS | Genetics vOLume 12 | feBRuARy 2011 | 95 © 2011 Macmillan Publishers Limited . All rights reserved (cid:48)(cid:67)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:52)(cid:71)(cid:88)(cid:75)(cid:71)(cid:89)(cid:85)(cid:2) (cid:94) (cid:2)(cid:41)(cid:71)(cid:80)(cid:71)(cid:86)(cid:75)(cid:69)(cid:85) (cid:37)(cid:71)(cid:78)(cid:78)(cid:2)(cid:78)(cid:91)(cid:85)(cid:75)(cid:85)(cid:2)(cid:67)(cid:80)(cid:70)(cid:2)(cid:85)(cid:87)(cid:84)(cid:72)(cid:67)(cid:69)(cid:71)(cid:2)(cid:69)(cid:67)(cid:82)(cid:86)(cid:87)(cid:84)(cid:71) (cid:50)(cid:81)(cid:78)(cid:91)(cid:10)(cid:70)(cid:54)(cid:11)(cid:2)(cid:69)(cid:81)(cid:67)(cid:86)(cid:71)(cid:70)(cid:2)(cid:85)(cid:87)(cid:84)(cid:72)(cid:67)(cid:69)(cid:71) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:35)(cid:35)(cid:35)(cid:35)(cid:35) (cid:37)(cid:71)(cid:78)(cid:78)(cid:2)(cid:70)(cid:71)(cid:78)(cid:75)(cid:88)(cid:71)(cid:84)(cid:91)(cid:2)(cid:86)(cid:81)(cid:2)(cid:559)(cid:81)(cid:89)(cid:2)(cid:69)(cid:71)(cid:78)(cid:78) (cid:67) (cid:68) (cid:53)(cid:81)(cid:78)(cid:87)(cid:86)(cid:75)(cid:81)(cid:80)(cid:2)(cid:82)(cid:74)(cid:67)(cid:85)(cid:71)(cid:74)(cid:91)(cid:68)(cid:84)(cid:75)(cid:70)(cid:75)(cid:92)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80) (cid:54)(cid:67)(cid:84)(cid:73)(cid:71)(cid:86)(cid:115)(cid:82)(cid:84)(cid:81)(cid:68)(cid:71)(cid:2)(cid:69)(cid:81)(cid:79)(cid:82)(cid:78)(cid:71)(cid:90) (cid:43)(cid:79)(cid:79)(cid:81)(cid:68)(cid:75)(cid:78)(cid:75)(cid:92)(cid:67)(cid:86)(cid:75)(cid:81)(cid:80)(cid:81)(cid:72)(cid:2)(cid:69)(cid:81)(cid:79)(cid:82)(cid:78)(cid:71)(cid:90)(cid:71)(cid:85) (cid:43)(cid:79)(cid:67)(cid:73)(cid:71) (cid:52)(cid:71)(cid:88)(cid:71)(cid:84)(cid:85)(cid:71)(cid:2)(cid:86)(cid:84)(cid:67)(cid:80)(cid:85)(cid:69)(cid:84)(cid:75)(cid:82)(cid:86)(cid:75)(cid:81)(cid:80)(cid:67)(cid:80)(cid:70)(cid:2)(cid:69)(cid:38)(cid:48)(cid:35)(cid:2)(cid:85)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:75)(cid:80)(cid:73)(cid:2) (cid:38)(cid:75)(cid:84)(cid:71)(cid:69)(cid:86)(cid:2)(cid:52)(cid:48)(cid:35)(cid:2)(cid:85)(cid:71)(cid:83)(cid:87)(cid:71)(cid:80)(cid:69)(cid:75)(cid:80)(cid:73) (cid:49)(cid:84) (cid:52)(cid:48)(cid:35) (cid:52)(cid:71)(cid:82)(cid:81)(cid:84)(cid:86)(cid:71)(cid:84)(cid:2)(cid:82)(cid:84)(cid:81)(cid:68)(cid:71) (cid:37)(cid:67)(cid:82)(cid:86)(cid:87)(cid:84)(cid:71)(cid:2)(cid:82)(cid:84)(cid:81)(cid:68)(cid:71) Quantitative real - time polymerase chain reaction A PCR application that enables the measurement of nucleic acid quantities in samples . Nucleic acid of interest is amplified with PCR . The level of the amplified product accumulation during PCR cycles are measured in real time . This data is used to infer starting nucleic acid quantities . Circulating extracellular nucleic acid Extracellular DNA or RNA molecules in plasma and serum . fluidigm offers a microfluidics platform that can perform quantitative real - time polymerase chain reaction ( qRT - PCR ) experiments on gene panels in a multi - plexed manner and has been used to profile single cells . Commercial kits allowing one - step cDNA synthesis and amplification are used for cell lysis , cDNA syn - thesis and PCR amplification of the transcript region of interest . Pre - amplified cDNAs are then introduced to the fluidigm Dynamic Array for qRT - PCR analysis . This approach may be useful for the determination of the expression levels of a subset of transcripts across cells of interest 101 , 102 . None of the approaches described above is mature , and none so far fully addresses our need for reliable , genome - wide and in - depth transcriptome profiles from minute cell quantities . for example , both the fluidigm and NanoString technologies interrogate only a selected subset of transcripts and do not pro - vide comprehensive analyses . However , it is hoped that future advances that will arise from the founda - tion formed by these technologies will enable such capabilities . Future perspectives Recent advances in RNA - seq have provided researchers with a powerful toolbox for the characterization and quantification of the transcriptome . emerging sequencing technologies promise to at least partly alleviate the difficulties of current RNA - seq methods and equip scientists with better tools . using these tech - nological advances , we can build a complete catalogue of transcripts that are derived from genomes ranging from those of simple unicellular organisms to complex mammalian cells , as well as in tissues in normal and disease states . furthermore , with our increasing ability to work with minute RNA quantities from fresh and formalin - fixed paraffin - embedded tissues and cells , and to provide quantification of RNA species from even single cells , we have the opportunity to define complex biological networks in a wide range of bio - logical specimens . With these networks in hand , we can use data - driven RNA network models of cells and tissues in an attempt to fully understand the biological pathways that are active in various physiological con - ditions . In addition , these technologies are bringing us closer to the ability to use RNA measurements for clinical diagnostics . for example , analysis of circulating extracellular nucleic acid 103 and cells , such as fetal RNA and circulating tumour cells , with these new tech - nologies may allow for earlier assessment of health , disease recurrence or mutational status . Thus , these technologies will continue to help us realize the full potential of genomic information as it relates to basic biological questions of differentiation and diversity , as well as its growing impact on the personalization of healthcare . Figure 5 | emerging technologies for single - cell or low - quantity - cell gene expression profiling . a | Single - molecule DNA and RNA sequencing technologies could be modified for single - cell applications . Cells can be delivered to flow cells using fluidics systems , followed by cell lysis and capture of mRNA species on the poly ( dT ) - coated sequencing surfaces by hybridization . Standard sequencing runs could take place on channels with a 127 . 5 mm 2 surface area , requiring 2 , 750 images to be taken per cycle to image the entire channel area . The surface area needed to accommodate ~ 350 , 000 mRNA molecules contained in a single cell is ~ 0 . 4 mm 2 ; thus , only eight images per cycle would be needed . Sequence analysis can be done with direct RNA sequencing ( DRS ) 7 or on - surface cDNA synthesis followed by single - molecule DNA sequencing 26 . b | Counter system workflow . Two probes are used for each target site : the capture probe ( shown in red ) contains a target - specific sequence and a modification that allows the immobilization of the molecules on a surface ; the reporter probe contains a different target - specific sequence ( shown in blue ) and a fluorescent barcode ( shown by a green circle ) that is unique to each target being examined . After hybridization of the capture and reporter probe mixture to RNA samples in solution , excess probes are removed . The hybridized RNA duplexes are then immobilized on a surface and imaged to identify and count each transcript with the unique fluorescent signals on the capture and reporter probes . R E V I E W S 96 | feBRuARy 2011 | vOLume 12 www . nature . com / reviews / genetics © 2011 Macmillan Publishers Limited . All rights reserved 1 . Birney , E . et al . Identification and analysis of functional elements in 1 % of the human genome by the ENCODE pilot project . Nature 447 , 799 – 816 ( 2007 ) . 2 . Berretta , J . & Morillon , A . Pervasive transcription constitutes a new level of eukaryotic genome regulation . EMBO Rep . 10 , 973 – 982 ( 2009 ) . 3 . Kapranov , P . , Willingham , A . T . & Gingeras , T . R . Genome - wide transcription and the implications for genomic organization . Nature Rev . Genet . 8 , 413 – 423 ( 2007 ) . 4 . Metzker , M . L . Sequencing technologies — the next generation . Nature Rev . Genet . 11 , 31 – 46 ( 2010 ) . This Review provides a comprehensive overview of currently available and in - development NGS technologies . 5 . Wang , Z . , Gerstein , M . & Snyder , M . RNA - seq : a revolutionary tool for transcriptomics . Nature Rev . Genet . 10 , 57 – 63 ( 2009 ) . 6 . van Vliet , A . H . Next generation sequencing of microbial transcriptomes : challenges and opportunities . FEMS Microbiol . Lett . 302 , 1 – 7 ( 2010 ) . 7 . Ozsolak , F . et al . Direct RNA sequencing . Nature 461 , 814 – 818 ( 2009 ) . The first technology for high - throughput direct sequencing of RNA molecules without prior reverse transcription . 8 . Carninci , P . et al . Genome - wide analysis of mammalian promoter architecture and evolution . Nature Genet . 38 , 626 – 635 ( 2006 ) . 9 . Shiraki , T . et al . Cap analysis gene expression for high - throughput analysis of transcriptional starting point and identification of promoter usage . Proc . Natl Acad . Sci . USA 100 , 15776 – 15781 ( 2003 ) . 10 . Valen , E . et al . Genome - wide detection and analysis of hippocampus core promoters using DeepCAGE . Genome Res . 19 , 255 – 265 ( 2009 ) . 11 . Ni , T . et al . A paired - end sequencing strategy to map the complex landscape of transcription initiation . Nature Methods 7 , 521 – 527 ( 2010 ) . 12 . Plessy , C . et al . Linking promoters to functional transcripts in small samples with nanoCAGE and CAGEscan . Nature Methods 7 , 528 – 534 ( 2010 ) . 13 . Marson , A . et al . Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells . Cell 134 , 521 – 533 ( 2008 ) . 14 . Ozsolak , F . et al . Chromatin structure analyses identify miRNA promoters . Genes Dev . 22 , 3172 – 3183 ( 2008 ) . 15 . Affymetrix / Cold Spring Harbor Laboratory ENCODE Transcriptome Project . Post - transcriptional processing generates a diversity of 5 ′ - modified long and short RNAs . Nature 457 , 1028 – 1032 ( 2009 ) . This paper raises the possibility of 5 ′ - cap addition during post - transcriptional processing steps . 16 . Faghihi , M . A . & Wahlestedt , C . Regulatory roles of natural antisense transcripts . Nature Rev . Mol . Cell Biol . 10 , 637 – 643 ( 2009 ) . An excellent review of the literature on sense and antisense transcription . 17 . Gubler , U . Second - strand cDNA synthesis : mRNA fragments as primers . Meth . Enzymol . 152 , 330 – 335 ( 1987 ) . 18 . Perocchi , F . , Xu , Z . , Clauder - Munster , S . & Steinmetz , L . M . Antisense artifacts in transcriptome microarray experiments are resolved by actinomycin D . Nucleic Acids Res . 35 , e128 ( 2007 ) . 19 . Spiegelman , S . et al . DNA - directed DNA polymerase activity in oncogenic RNA viruses . Nature 227 , 1029 – 1031 ( 1970 ) . 20 . Wu , J . Q . et al . Systematic analysis of transcribed loci in ENCODE regions using RACE sequencing reveals extensive transcription in the human genome . Genome Biol . 9 , R3 ( 2008 ) . 21 . Cloonan , N . et al . Stem cell transcriptome profiling via massive - scale mRNA sequencing . Nature Methods 5 , 613 – 619 ( 2008 ) . 22 . Core , L . J . , Waterfall , J . J . & Lis , J . T . Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters . Science 322 , 1845 – 1848 ( 2008 ) . 23 . Mamanova , L . et al . FRT - seq : amplification - free , strand - specific transcriptome sequencing . Nature Methods 7 , 130 – 132 ( 2010 ) . 24 . Lipson , D . et al . Quantification of the yeast transcriptome by single - molecule sequencing . Nature Biotechnol . 27 , 652 – 658 ( 2009 ) . 25 . Ozsolak , F . et al . Digital transcriptome profiling from attomole - level RNA samples . Genome Res . 20 , 519 – 525 ( 2010 ) . 26 . Ozsolak , F . et al . Amplification - free digital gene expression profiling from minute cell quantities . Nature Methods 7 , 619 – 621 ( 2010 ) . 27 . He , Y . , Vogelstein , B . , Velculescu , V . E . , Papadopoulos , N . & Kinzler , K . W . The antisense transcriptomes of human cells . Science 322 , 1855 – 1857 ( 2008 ) . 28 . Parkhomchuk , D . et al . Transcriptome analysis by strand - specific sequencing of complementary DNA . Nucleic Acids Res . 37 , e123 ( 2009 ) . 29 . Ingolia , N . T . , Ghaemmaghami , S . , Newman , J . R . & Weissman , J . S . Genome - wide analysis in vivo of translation with nucleotide resolution using ribosome profiling . Science 324 , 218 – 223 ( 2009 ) . 30 . Levin , J . Z . et al . Comprehensive comparative analysis of strand - specific RNA sequencing methods . Nature Methods 7 , 709 – 715 ( 2010 ) . 31 . Faulhammer , D . , Lipton , R . J . & Landweber , L . F . Fidelity of enzymatic ligation for DNA computing . J . Comput . Biol . 7 , 839 – 848 ( 2000 ) . 32 . Housby , J . N . & Southern , E . M . Fidelity of DNA ligation : a novel experimental approach based on the polymerisation of libraries of oligonucleotides . Nucleic Acids Res . 26 , 4259 – 4266 ( 1998 ) . 33 . Dohm , J . C . , Lottaz , C . , Borodina , T . & Himmelbauer , H . Substantial biases in ultra - short read data sets from high - throughput DNA sequencing . Nucleic Acids Res . 36 , e105 ( 2008 ) . 34 . Goren , A . et al . Chromatin profiling by directly sequencing small quantities of immunoprecipitated DNA . Nature Methods 7 , 47 – 49 ( 2010 ) . 35 . Kozarewa , I . et al . Amplification - free Illumina sequencing - library preparation facilitates improved mapping and assembly of ( G + C ) - biased genomes . Nature Methods 6 , 291 – 295 ( 2009 ) . 36 . Nilsen , T . W . & Graveley , B . R . Expansion of the eukaryotic proteome by alternative splicing . Nature 463 , 457 – 463 ( 2010 ) . 37 . Wang , G . S . & Cooper , T . A . Splicing in disease : disruption of the splicing code and the decoding machinery . Nature Rev . Genet . 8 , 749 – 761 ( 2007 ) . 38 . Mortazavi , A . , Williams , B . A . , McCue , K . , Schaeffer , L . & Wold , B . Mapping and quantifying mammalian transcriptomes by RNA - seq . Nature Methods 5 , 621 – 628 ( 2008 ) . 39 . Sultan , M . et al . A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome . Science 321 , 956 – 960 ( 2008 ) . 40 . Tang , F . et al . mRNA - seq whole - transcriptome analysis of a single cell . Nature Methods 6 , 377 – 382 ( 2009 ) . 41 . Wang , E . T . et al . Alternative isoform regulation in human tissue transcriptomes . Nature 456 , 470 – 476 ( 2008 ) . 42 . Carninci , P . Is sequencing enlightenment ending the dark age of the transcriptome ? Nature Methods 6 , 711 – 713 ( 2009 ) . 43 . Jiang , H . & Wong , W . H . Statistical inferences for isoform expression in RNA - seq . Bioinformatics 25 , 1026 – 1032 ( 2009 ) . 44 . Richard , H . et al . Prediction of alternative isoforms from exon expression levels in RNA - seq experiments . Nucleic Acids Res . 38 , e112 ( 2010 ) . 45 . Ameur , A . , Wetterbom , A . , Feuk , L . & Gyllensten , U . Global and unbiased detection of splice junctions from RNA - seq data . Genome Biol . 11 , R34 ( 2010 ) . 46 . Trapnell , C . , Pachter , L . & Salzberg , S . L . TopHat : discovering splice junctions with RNA - seq . Bioinformatics 25 , 1105 – 1111 ( 2009 ) . 47 . Eid , J . et al . Real - time DNA sequencing from single polymerase molecules . Science 323 , 133 – 138 ( 2009 ) . 48 . Olasagasti , F . et al . Replication of individual DNA molecules under electronic control using a protein nanopore . Nature Nanotech . 5 , 798 – 806 ( 2010 ) . 49 . Mitelman , F . , Johansson , B . & Mertens , F . The impact of translocations and gene fusions on cancer causation . Nature Rev . Cancer 7 , 233 – 245 ( 2007 ) . 50 . Korbel , J . O . et al . Paired - end mapping reveals extensive structural variation in the human genome . Science 318 , 420 – 426 ( 2007 ) . 51 . Maher , C . A . et al . Transcriptome sequencing to detect gene fusions in cancer . Nature 458 , 97 – 101 ( 2009 ) . 52 . Zhao , Q . et al . Transcriptome - guided characterization of genomic rearrangements in a breast cancer cell line . Proc . Natl Acad . Sci . USA 106 , 1886 – 1891 ( 2009 ) . 53 . Li , H . , Wang , J . , Mor , G . & Sklar , J . A neoplastic gene fusion mimics trans - splicing of RNAs in normal human cells . Science 321 , 1357 – 1361 ( 2008 ) . 54 . Maher , C . A . et al . Chimeric transcript discovery by paired - end transcriptome sequencing . Proc . Natl Acad . Sci . USA 106 , 12353 – 12358 ( 2009 ) . 55 . Berger , M . F . et al . Integrative analysis of the melanoma transcriptome . Genome Res . 20 , 413 – 427 ( 2010 ) . 56 . Palanisamy , N . et al . Rearrangements of the RAF kinase pathway in prostate cancer , gastric cancer and melanoma . Nature Med . 16 , 793 – 798 ( 2010 ) . 57 . McManus , C . J . , Duff , M . O . , Eipper - Mains , J . & Graveley , B . R . Global analysis of trans - splicing in Drosophila . Proc . Natl Acad . Sci . USA 107 , 12975 – 12979 ( 2010 ) . 58 . Garber , K . Fixing the front end . Nature Biotech . . 26 , 1101 – 1104 ( 2008 ) . 59 . Chepelev , I . , Wei , G . , Tang , Q . & Zhao , K . Detection of single nucleotide variations in expressed exons of the human genome using RNA - seq . Nucleic Acids Res . 37 , e106 ( 2009 ) . 60 . Cirulli , E . T . et al . Screening the human exome : a comparison of whole genome and whole transcriptome sequencing . Genome Biol . 11 ( 2010 ) . 61 . Shah , S . P . et al . Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution . Nature 461 , 809 – 813 ( 2009 ) . 62 . Levin , J . Z . et al . Targeted next - generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts . Genome Biol . 10 , R115 ( 2009 ) . 63 . Li , J . B . et al . Genome - wide identification of human RNA editing sites by parallel DNA capturing and sequencing . Science 324 , 1210 – 1213 ( 2009 ) . 64 . Zhang , K . et al . Digital RNA allelotyping reveals tissue - specific and allele - specific gene expression in human . Nature Methods 6 , 613 – 618 ( 2009 ) . 65 . Ghildiyal , M . & Zamore , P . D . Small silencing RNAs : an expanding universe . Nature Rev . Genet . 10 , 94 – 108 ( 2009 ) . 66 . Rajagopalan , R . , Vaucheret , H . , Trejo , J . & Bartel , D . P . A diverse and evolutionarily fluid set of microRNAs in Arabidopsis thaliana . Genes Dev . 20 , 3407 – 3425 ( 2006 ) . 67 . Ruby , J . G . et al . Large - scale sequencing reveals 21U - RNAs and additional microRNAs and endogenous siRNAs in C . elegans . Cell 127 , 1193 – 1207 ( 2006 ) . 68 . Seila , A . C . et al . Divergent transcription from active promoters . Science 322 , 1849 – 1851 ( 2008 ) . 69 . Taft , R . J . et al . Tiny RNAs associated with transcription start sites in animals . Nature Genet . 41 , 572 – 578 ( 2009 ) . 70 . Berezikov , E . et al . Diversity of microRNAs in human and chimpanzee brain . Nature Genet . 38 , 1375 – 1377 ( 2006 ) . 71 . Kapranov , P . et al . New class of gene - termini - associated human RNAs suggests a novel RNA copying mechanism . Nature 466 , 642 – 646 ( 2010 ) . 72 . Lau , N . C . , Lim , L . P . , Weinstein , E . G . & Bartel , D . P . An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans . Science 294 , 858 – 862 ( 2001 ) . 73 . Kawaji , H . & Hayashizaki , Y . Exploration of small RNAs . PLoS Genet . 4 , e22 ( 2008 ) . 74 . Linsen , S . E . et al . Limitations and possibilities of small RNA digital gene expression profiling . Nature Methods 6 , 474 – 476 ( 2009 ) . The authors describe the difficulties associated with the analysis and quantification of short RNA species using current NGS platforms . 75 . Cocquet , J . , Chong , A . , Zhang , G . & Veitia , R . A . Reverse transcriptase template switching and false alternative transcripts . Genomics 88 , 127 – 131 ( 2006 ) . 76 . Mader , R . M . et al . Reverse transcriptase template switching during reverse transcriptase - polymerase chain reaction : artificial generation of deletions in ribonucleotide reductase mRNA . J . Lab . Clin . Med . 137 , 422 – 428 ( 2001 ) . 77 . Roy , S . W . & Irimia , M . When good transcripts go bad : artifactual RT - PCR ‘splicing’ and genome analysis . Bioessays 30 , 601 – 605 ( 2008 ) . 78 . Chen , D . & Patton , J . T . Reverse transcriptase adds nontemplated nucleotides to cDNAs during 5 ′ - RACE and primer extension . Biotechniques 30 , 574 – 582 ( 2001 ) . 79 . Roberts , J . D . et al . Fidelity of two retroviral reverse transcriptases during DNA - dependent DNA synthesis in vitro . Mol . Cell . Biol . 9 , 469 – 476 ( 1989 ) . 80 . Armour , C . D . et al . Digital transcriptome profiling using selective hexamer priming for cDNA synthesis . Nature Methods 6 , 647 – 649 ( 2009 ) . R E V I E W S NATuRe RevIeWS | Genetics vOLume 12 | feBRuARy 2011 | 97 © 2011 Macmillan Publishers Limited . All rights reserved 81 . Hansen , K . D . , Brenner , S . E . & Dudoit , S . Biases in Illumina transcriptome sequencing caused by random hexamer priming . Nucleic Acids Res . 38 , e131 ( 2010 ) . 82 . Rosenkranz , R . , Borodina , T . , Lehrach , H . & Himmelbauer , H . Characterizing the mouse ES cell transcriptome with Illumina sequencing . Genomics 92 , 187 – 194 ( 2008 ) . 83 . Oshlack , A . & Wakefield , M . J . Transcript length bias in RNA - seq data confounds systems biology . Biol . Direct 4 , 14 ( 2009 ) . 84 . Young , M . D . , Wakefield , M . J . , Smyth , G . K . & Oshlack , A . Gene ontology analysis for RNA - seq : accounting for selection bias . Genome Biol . 11 , R14 ( 2010 ) . 85 . Li , B . , Ruotti , V . , Stewart , R . M . , Thomson , J . A . & Dewey , C . N . RNA - seq gene expression estimation with read mapping uncertainty . Bioinformatics 26 , 493 – 500 ( 2010 ) . 86 . Guttman , M . et al . Ab initio reconstruction of cell type - specific transcriptomes in mouse reveals the conserved multi - exonic structure of lincRNAs . Nature Biotech . 28 , 503 – 510 ( 2010 ) . 87 . Trapnell , C . et al . Transcript assembly and quantification by RNA - seq reveals unannotated transcripts and isoform switching during cell differentiation . Nature Biotech . 28 , 511 – 515 ( 2010 ) . 88 . Shcherbik , N . , Wang , M . , Lapik , Y . R . , Srivastava , L . & Pestov , D . G . Polyadenylation and degradation of incomplete RNA polymerase I transcripts in mammalian cells . EMBO Rep . 11 , 106 – 111 ( 2010 ) . 89 . Makeyev , E . V . & Bamford , D . H . Replicase activity of purified recombinant protein P2 of double - stranded RNA bacteriophage phi6 . EMBO J . 19 , 124 – 133 ( 2000 ) . 90 . Gurumurthy , S . et al . The Lkb1 metabolic sensor maintains haematopoietic stem cell survival . Nature 468 , 659 – 63 ( 2010 ) . 91 . Ozsolak , F . et al . Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation . Cell 143 , 1018 – 1029 ( 2010 ) . 92 . Simone , N . L . , Bonner , R . F . , Gillespie , J . W . , Emmert - Buck , M . R . & Liotta , L . A . Laser - capture microdissection : opening the microscopic frontier to molecular analysis . Trends Genet . 14 , 272 – 276 ( 1998 ) . 93 . Marcy , Y . et al . Dissecting biological “dark matter” with single - cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth . Proc . Natl Acad . Sci . USA 104 , 11889 – 11894 ( 2007 ) . 94 . Pfeifer , G . P . , Steigerwald , S . D . , Mueller , P . R . , Wold , B . & Riggs , A . D . Genomic sequencing and methylation analysis by ligation mediated PCR . Science 246 , 810 – 813 ( 1989 ) . 95 . Dean , F . B . et al . Comprehensive human genome amplification using multiple displacement amplification . Proc . Natl Acad . Sci . USA 99 , 5261 – 5266 ( 2002 ) . 96 . Dafforn , A . et al . Linear mRNA amplification from as little as 5 ng total RNA for global gene expression analysis . Biotechniques 37 , 854 – 857 ( 2004 ) . 97 . Eberwine , J . et al . Analysis of gene expression in single live neurons . Proc . Natl Acad . Sci . USA 89 , 3010 – 3014 ( 1992 ) . 98 . Nygaard , V . & Hovig , E . Options available for profiling small samples : a review of sample amplification technology when combined with microarray profiling . Nucleic Acids Res . 34 , 996 – 1014 ( 2006 ) . This review provides a good overview of the current low - quantity RNA applications and the complications associated with them . 99 . Geiss , G . K . et al . Direct multiplexed measurement of gene expression with color - coded probe pairs . Nature Biotech . 26 , 317 – 325 ( 2008 ) . 100 . Amit , I . et al . Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses . Science 326 , 257 – 263 ( 2009 ) . 101 . Byrne , J . A . , Nguyen , H . N . & Reijo Pera , R . A . Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts . PLoS ONE 4 , e7118 ( 2009 ) . 102 . Helzer , K . T . et al . Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model . Cancer Res . 69 , 7860 – 7866 ( 2009 ) . 103 . Lo , Y . M . et al . Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection . Nature Med . 13 , 218 – 223 ( 2007 ) . This paper describes the quantification of extracellular circulating RNA in mother’s plasma during pregnancy to detect fetal aneuploidy . 104 . Bowers , J . et al . Virtual terminator nucleotides for next - generation DNA sequencing . Nature Methods 6 , 593 – 595 ( 2009 ) . Acknowledgements We apologize to authors whose work could not be cited owing to space constraints . We are grateful to the US National Human Genome Research Institute for their support ( grants R01 HG005230 and R44 HG005279 ) . Competing interests statement The authors declare competing financial interests ; see Web version for details . FUrTHEr INFOrMATION Fatih Ozsolak and Patrice M . Milos’s homepage ( Helicos BioSciences website ) : www . helicosbio . com Helicos Technology Center : http : / / open . helicosbio . com The University of California Santa Cruz Genome Browser : http : / / genome . ucsc . edu All links ARe Active in tHe online pDf R E V I E W S 98 | feBRuARy 2011 | vOLume 12 www . nature . com / reviews / genetics © 2011 Macmillan Publishers Limited . All rights reserved